行情

WVE

WVE

WAVE LIFE SCIENC
NASDAQ

实时行情|Nasdaq Last Sale

32.42
+0.08
+0.25%
已收盘, 18:55 12/09 EST
开盘
32.45
昨收
32.34
最高
32.96
最低
31.61
成交量
23.31万
成交额
--
52周最高
50.98
52周最低
17.59
市值
11.12亿
市盈率(TTM)
-6.0648
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

WVE 新闻

  • Hedge Funds Love Liberty Tripadvisor (LTRPA) Way More Than These 3 Stocks
  • Insider Monkey.3天前
  • 意大利最大商业银行拟裁员8000人
  • 新浪财经.12/03 07:12
  • 意大利总理支持欧洲稳定机制改革 遭反对党批评
  • 中国新闻网.12/03 07:11
  • 韩2019网购销售额破100万亿韩元 披萨炸鸡交易额剧增
  • 中国新闻网.12/03 07:05

更多

所属板块

生物技术和医学研究
+0.51%
制药与医学研究
+0.23%

热门股票

名称
价格
涨跌幅

WVE 简况

WAVE Life Sciences Ltd. is a genetic medicines company. The Company, through its synthetic chemistry drug development platform, designs, develops and commercializes a pipeline of nucleic acid therapeutic candidates for genetically defined diseases. The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. The nucleic acid therapeutics, which the Company is developing are stereopure. A stereopure oligonucleotide includes molecules with atoms arranged in three-dimensional orientations at each linkage. The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates.
展开

Webull提供Wave Life Sciences Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。